Answers are grounded in this paper and cite their sources.
Pulmonary splenosis (PS) is a benign condition resulting from ectopic implantation of splenic tissue following splenic trauma or splenectomy. It can mimic metastatic disease, posing a significant diagnostic challenge, particularly in oncologic patients. We present a case of PS in a breast cancer patient initially misdiagnosed with lung metastases. A 43-year-old female patient with a history of splenectomy was diagnosed with grade III hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) invasive ductal carcinoma. Imaging suggested metastatic disease, with lung nodules and left subphrenic lesions. First-line treatment with letrozole and ribociclib was initiated. Subsequent imaging revealed stable disease and doubts about the metastatic nature of the lesions were raised. A history of prior splenic trauma and metabolic imaging consistent with splenosis led to a diagnosis of PS. The patient was reclassified as early-stage breast cancer, underwent right mastectomy with axillary lymph node dissection, and achieved a pathological complete response in the primary tumor. This case highlights the importance of considering PS in differential diagnoses for metastatic-like lesions, particularly in patients with a history of splenic trauma, to prevent misdiagnosis and unnecessary treatment. • Benign pulmonary lesions can mimic metastatic lesions and result in misdiagnosis. • It must be considered especially in cancer patients as it leads to mistreatment. • Pulmonary splenosis is a rare case in breast cancer patients. • This case underscores how pulmonary splenosis can lead to unnecessary treatments. • Full medical history is essential before treatment especially in cancer patients.
No takes yet. Share an insight, caveat, or question.
Haddaoui et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: